132nd MAINE LEGISLATURE
		LD 93		LR 253(02)
	An Act to Reduce Cost and Increase Access to Disease Prevention by Expanding the Universal Childhood Immunization Program to Include Adults
	Fiscal Note for Bill as Amended by Committee Amendment " "
	Committee: Health and Human Services
	Fiscal Note Required: Yes
Fiscal Note
			FY 2025-26	FY 2026-27	Projections  FY 2027-28	Projections  FY 2028-29
Net Cost (Savings)
	General Fund		$0	($302,107)	($553,935)	($553,935)
Appropriations/Allocations
	General Fund		$0	($302,107)	($553,935)	($553,935)
	Federal Expenditures Fund		$0	($260,619)	($648,754)	($641,677)
Revenue
	Federal Expenditures Fund		$0	($260,619)	($648,753)	($641,677)
Fiscal Detail and Notes
	Expanding the State's Universal Childhood Immunization Program to cover the costs of recommended vaccines for adults will enable the Department of Health and Human Services to procure vaccine for adults in the MaineCare program at the U.S. Centers for Disease Control and Prevention discounted vaccine prices. The bill includes General Fund deappropriations to the Department of Health and Human Services of $302,107 in fiscal year 2026-27 based on the cost savings from the discounted vaccine prices available to the MaineCare program. It also includes Federal Expenditure Fund deallocations for the FMAP match. Projected General Funds deappropriations and Federal Expenditure Fund deallocations are larger in future years as the changes in the bill are fully implemented. The bill also includes Federal Expenditure Funds allocations to the department of $221,561 in fiscal year 2026-27 for two federally-funded Public Health Educator III positions to implement the changes to the immunization program.
	The bill is expected to increase costs to the State Employee Health Plan (SEHP) through the assessments collected from insurers for adult vaccines purchased by the Universal Childhood Immunization Program and reduce costs to the SEHP as adult vaccines covered by the program will be available to medical providers at no cost, reducing insurance claims for adult vaccines. A more precise estimate of the net fiscal impact cannot be determined at this time.